What are the differences between CAR T-cell therapy and bispecific antibodies?
Автор: International Myeloma Foundation
Загружено: 2023-04-13
Просмотров: 4465
In this week’s #AskDrDurie, myeloma expert Dr. Brian G.M. Durie discusses the main differences between the CAR T cells and bispecific monoclonal antibodies.
The BOTTOM LINE: Discuss with your doctor to decide which treatment is available and appropriate for you.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: https://www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-foundation
Support the IMF | Donate Now! https://secure.myeloma.org/page/40697...
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
